Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 87 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  2. US 8304408

    Wnt signaling inhibitors, and methods for making and using them

    The Regents of the University of California · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  3. US 8299261

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  4. US 8299100

    Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

    Northwestern University · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  5. US 8293724

    Therapeutic applications of fatty acid amide hydrolase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  6. US 8293901

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  7. US 8293878

    Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  8. US 8288400

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  9. US 8288536

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  10. US 8288382

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  11. US 8288537

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  12. US 8288539

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  13. US 8283309

    Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  14. US 8278348

    Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  15. US 8278306

    C-met protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  16. US 8278297

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  17. US 8278299

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  18. US 8278305

    Myosin light chain kinase inhibitor compounds, compositions and related methods of use

    Northwestern University · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  19. US 8278450

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  20. US 8273746

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  21. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  22. US 8269013

    Substituted pyrazole inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  23. US 8268811

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  24. US 8268829

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted